Infusil Glastech Machines Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 27-12-2024
- Paid Up Capital ₹ 0.37 M
as on 27-12-2024
- Company Age 33 Year, 28 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.92 M
as on 27-12-2024
- Revenue 74.26%
(FY 2020)
- Profit 4206.85%
(FY 2020)
- Ebitda -1415.19%
(FY 2020)
- Net Worth 749.74%
(FY 2020)
- Total Assets 488.69%
(FY 2020)
About Infusil Glastech Machines
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.37 M.
The company currently has active open charges totaling ₹0.92 M.
Chitgopeker Manoj, Bhanu Swamy, and Swamy Ravi serve as directors at the Company.
- CIN/LLPIN
U29298KA1991PTC012614
- Company No.
012614
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Infusil Glastech Machines?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Chitgopeker Manoj | Director | 01-Feb-2012 | Current |
Bhanu Swamy | Director | 14-Feb-2014 | Current |
Swamy Ravi | Director | 18-Feb-1998 | Current |
Financial Performance of Infusil Glastech Machines.
Infusil Glastech Machines Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 74.26% increase. The company also saw a substantial improvement in profitability, with a 4206.85% increase in profit. The company's net worth Soared by an impressive increase of 749.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Infusil Glastech Machines?
In 2020, Infusil Glastech Machines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Infusil India Private LimitedActive 32 years 11 months
Chitgopeker Manoj, Bhanu Swamy and 1 more are mutual person
- Indian Fused Quartz Private LimitedActive 45 years 11 months
Chitgopeker Manoj, Bhanu Swamy and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 09 Nov 2022 | ₹0.92 M | Open |
How Many Employees Work at Infusil Glastech Machines?
Unlock and access historical data on people associated with Infusil Glastech Machines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Infusil Glastech Machines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infusil Glastech Machines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.